Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

James G. Wright, PhD

Director
Wright Dose Ltd, United Kingdom

Disclosure(s): F2G: Advisor/Consultant

Poster(s):

595 - Olorofim (OLO) for treatment of invasive mould infections in patients with limited or no treatment options: PK data from a Phase 2b open-label study (NCT03583164, Study 32)
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET